USPTO serial 79218094
LASER PCR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- THOMAS, JULIE
- Law office
- TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with LASER PCR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
82152 Martinsried, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline Zion
Jacqueline Zion Pearl Cohen Zedek Latzer Baratz LLP1500 Broadway, 12th FLNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; detergents for use in manufacturing processes for diagnostic reagents; enzymes for industrial purposes; enzyme preparations for industrial purposes; gold salts; preparations of microorganisms, other than for medical and veterinary use, namely, for conducting bioanalytical reference measurements, or preparations serving as positive control reagents in bioanalytical procedures; diagnostic reagents for scientific or research use for sale in kit form; biochemical for in vitro and in vivo scientific use; chemicals for use in immuno-assay testing other than medical or veterinary; chemicals for use in performing nucleic acid polymerase chain reactions other than medical or veterinary; chemical diagnostic reagents for industrial use; chemical products for diagnostic use, namely, diagnostic for scientific purposes; chemicals for use in multiplying nucleic acid amounts other than for medical or veterinary use; chemical reagents for use in analytical tests, other than for medical or veterinary use; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical reagents for molecular biology, other than for medical or veterinary use; chemical reagents for laboratory use, other than for medical or veterinary use; chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria for scientific use; diagnostic preparations for scientific purposes; diagnostic preparations, other than for medical or veterinary purposes; diagnostic reagents for in-vitro use other than medical; diagnostic reagents for scientific or research use, in particular for processing samples and amplifying and detecting target molecules of interest, other than for medical laboratory use; diagnostic substances, other than for medical use; diagnostic chemicals other than for medical or veterinary use; diagnostic chemicals for use in antibiotic susceptibility testing other than for medical use; in-vivo diagnostic reagents for scientific use; diagnostic preparations for scientific or research use other than for medical use; diagnostic testing materials, other than for medical use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents, except for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents for scientific use; immunoassay reagents, other than for medical use; clinical diagnostics, other than for medical or veterinary use; nucleic acids for laboratory use; nucleic acid for use in nucleic acid amplification processes other than for medical use; reagents for use in analytical tests other than for medical or veterinary purposes; reagents for use in biological processing other than for medical or veterinary purposes; reagents for use in diagnostic tests other than for medical or veterinary purposes; reagents for laboratory purposes other than for medical or veterinary purposes; reagents for in-vitro laboratory use other than for medical or veterinary purposes; reagents for testing the sterility of medical equipment; nucleic acid amplification reagents other than for medical use; nucleic recombinant acids for laboratory use | ACTIVE | — |
| 005 | Diagnostic chemical reagents for medical use; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for veterinary purposes; diagnostic biomarker reagents for medical purposes; diagnostic testing materials for medical use testing of the intended performance characteristics of bioanalytical methods; diagnostic reagents for medical use; clinical medical reagents; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use with analyzers for medical purposes | ACTIVE | — |
| 009 | Biochips for research or scientific purposes; diagnostic apparatus, not for medical purposes, namely, for bioanalytical purposes, in particular for nucleic acid amplification and detection; computer software applications, downloadable, for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; chemistry apparatus and instruments, in particular temperature cyclers, heating devices and fluorescence scanners; recorded computer programs for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; downloadable computer software programs for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; recorded computer software for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; DNA chips; air analysis apparatus; optical apparatus and instruments, namely, for bioanalytical measurements, in particular optical heating instruments and optical fluorescence scanners; laboratory equipment, namely, test tubes; probes for scientific purposes for conducting bioanalytical measurements, in particular for nucleic acid amplification and detection; scientific, electrotechnical, electronic, optical, measuring, signaling, checking, and supervision apparatus and instruments, namely, in particular electrical heating apparatus and instruments; laboratory apparatus, analysis apparatus and parts therefor, namely, heating apparatus, temperature cyclers and fluorescence scanners; scanners; laboratory equipment, in particular apparatus for bioanalysis, in particular temperature cyclers, fluorescence scanners and apparatuses for nucleic acid amplification and detection, in particular using a cartridge for preparing samples, purifying nucleic acids and amplifying nucleic acids and for detecting nucleic acids; disposable articles for laboratory apparatus, in particular reaction vessels, sample tube holders and reaction chambers; parts and fittings for all the aforesaid, namely, replacement parts, extensions, modifications, and connection parts | ACTIVE | — |
| 010 | Apparatus for DNA and RNA exams for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes for detecting target molecules of interest in a sample, in particular a patient sample; medical apparatus, in particular apparatus for bioanalysis with a cartridge, in particular as a reaction chamber, for preparing samples, purifying nucleic acids, amplifying nucleic acids and optical detection, namely, the extraction, amplification, and detection of target molecules of interest; diagnostic apparatus for veterinary purposes for detecting target molecules of interest; automatic analyzers for medical diagnosis for detecting target molecules of interest; medical apparatus and instruments, namely, for detecting target molecules of interest; medical instruments for infectious disease testing, namely, instruments for cleaning and preparing samples and for amplifying and detecting nucleic acids; medical and veterinary apparatus and instruments, namely, for processing samples, and detecting target molecules of interest; tools for veterinary diagnostics, namely, detecting target molecules of interest | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2020 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 26, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 25, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 9, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 25, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 25, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 9, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 9, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 9, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 29, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 13, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 13, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 15, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 15, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 10, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 8, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 8, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 7, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 10, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 17, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 29, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 29, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 15, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 14, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 17, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 13, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 12, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |